Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 5
1949 1
1950 7
1951 10
1952 19
1953 17
1954 23
1955 18
1956 17
1957 15
1958 17
1959 23
1960 13
1961 19
1962 16
1963 14
1964 17
1965 6
1976 1
1979 3
1988 4
1989 12
1990 29
1991 30
1992 21
1993 22
1994 70
1995 209
1996 308
1997 356
1998 328
1999 407
2000 369
2001 437
2002 612
2003 678
2004 781
2005 1029
2006 1040
2007 1147
2008 1196
2009 1354
2010 1481
2011 1655
2012 1716
2013 1689
2014 1791
2015 1696
2016 1759
2017 1783
2018 1789
2019 1770
2020 1879
2021 1637
2022 1223
2023 1049
2024 574

Search Results

29,601 results

Results by year

Filters applied: . Clear all
Page 1
Rheumatoid arthritis.
Di Matteo A, Bathon JM, Emery P. Di Matteo A, et al. Lancet. 2023 Nov 25;402(10416):2019-2033. doi: 10.1016/S0140-6736(23)01525-8. Epub 2023 Oct 27. Lancet. 2023. PMID: 38240831 Review.
Structural disease modification in axial spondyloarthritis.
Dinneen B, O'Shea F, Gensler L. Dinneen B, et al. Best Pract Res Clin Rheumatol. 2023 Sep;37(3):101898. doi: 10.1016/j.berh.2023.101898. Epub 2023 Dec 1. Best Pract Res Clin Rheumatol. 2023. PMID: 38042689 Review.
Methotrexate osteopathy.
Youssef M, Youssef P. Youssef M, et al. Intern Med J. 2023 Nov;53(11):2141-2142. doi: 10.1111/imj.16265. Intern Med J. 2023. PMID: 37997267 No abstract available.
Recent advances and evolving concepts in Still's disease.
Ruscitti P, Cantarini L, Nigrovic PA, McGonagle D, Giacomelli R. Ruscitti P, et al. Nat Rev Rheumatol. 2024 Feb;20(2):116-132. doi: 10.1038/s41584-023-01065-6. Epub 2024 Jan 11. Nat Rev Rheumatol. 2024. PMID: 38212542 Review.
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Aymon R, Mongin D, Bergstra SA, Choquette D, Codreanu C, De Cock D, Dreyer L, Elkayam O, Huschek D, Hyrich KL, Iannone F, Inanc N, Kearsley-Fleet L, Koca SS, Kvien TK, Leeb BF, Lukina G, Nordström DC, Pavelka K, Pombo-Suarez M, Rodrigues A, Rotar Z, Strangfeld A, Verschueren P, Westermann R, Zavada J, Courvoisier DS, Finckh A, Lauper K. Aymon R, et al. Ann Rheum Dis. 2024 Mar 12;83(4):421-428. doi: 10.1136/ard-2023-224670. Ann Rheum Dis. 2024. PMID: 38071508 Free PMC article.
Communicating medication risk-is seeing believing?
Chauhan S, Khan T, Paul A. Chauhan S, et al. Rheumatology (Oxford). 2024 May 3;63(6):e172-e173. doi: 10.1093/rheumatology/kead706. Rheumatology (Oxford). 2024. PMID: 38145488 No abstract available.
29,601 results
You have reached the last available page of results. Please see the User Guide for more information.